» Articles » PMID: 23742804

Psychopathology and Psychosocial Adjustment in Patients with HIV-associated Lipodystrophy

Overview
Date 2013 Jun 8
PMID 23742804
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study whether patients with HIV-1 associated lipodystrophy (LD) on highly active antiretroviral treatment (HAART) have more psychopathology and worse psychosocial adjustment than a similar group without this syndrome.

Methods: In a cross-sectional, observational study we compared 47 HIV-1 infected patients with LD (LD group) with 39 HIV-1 infected patients without LD (non-LD group). All participants were on HAART. The Beck Depression Inventory (BDI), the State and Trait Anxiety Inventory (STAI) and the Goldberg Health Questionnaire (GHQ-60) were administered. Levels of familial, work and social adjustment and adjustment to stressful events were evaluated in a semi-structured interview. Clinical information was extracted from the clinical records.

Results: In the univariate analysis patients with LD showed higher state anxiety scores (p=0.009) and worse work adjustment (p=0.019) than those without LD. A total of 45.3% of LD patients scored above the cut-off point on the trait anxiety scale, and over 33.3% scored above the cut-off point on the BDI, GHQ and state anxiety scales. However, in multivariate analyses LD was not independently associated with psychopathology or with worse adjustment in the studied areas.

Conclusions: The finding that LD was not a predictor of greater psychopathology or worse psychosocial adjustment in HIV-1 infected patients, despite the high scores found, suggests that factors not taken into account in this study, such as LD severity and self-perception should have been included in the analysis. Further studies including a greater number of variables and a larger sample size will advance our understanding of this complex condition.

Citing Articles

Associations of depression and anxiety with cardiovascular risk among people living with HIV/AIDS in Korea.

Park K, Hwang S, Choi B, Kim J, Kim S, Kim W Epidemiol Health. 2021; 43:e2021002.

PMID: 33445826 PMC: 7952836. DOI: 10.4178/epih.e2021002.


Lipodystrophy among HIV-infected patients: a cross-sectional study on impact on quality of life and mental health disorders.

Verolet C, Delhumeau-Cartier C, Sartori M, Toma S, Zawadynski S, Becker M AIDS Res Ther. 2015; 12:21.

PMID: 26097493 PMC: 4475332. DOI: 10.1186/s12981-015-0061-z.

References
1.
Collins E, Wagner C, Walmsley S . Psychosocial impact of the lipodystrophy syndrome in HIV infection. AIDS Read. 2000; 10(9):546-50. View

2.
Palella Jr F, Delaney K, Moorman A, Loveless M, Fuhrer J, Satten G . Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998; 338(13):853-60. DOI: 10.1056/NEJM199803263381301. View

3.
Hays R, Cunningham W, Sherbourne C, Wilson I, Wu A, Cleary P . Health-related quality of life in patients with human immunodeficiency virus infection in the United States: results from the HIV Cost and Services Utilization Study. Am J Med. 2000; 108(9):714-22. DOI: 10.1016/s0002-9343(00)00387-9. View

4.
Fehr J, Nicca D, Sendi P, Wolf E, Wagels T, Kiss A . Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection. 2005; 33(4):249-56. DOI: 10.1007/s15010-005-4141-1. View

5.
Lyketsos C, Hutton H, Fishman M, Schwartz J, Treisman G . Psychiatric morbidity on entry to an HIV primary care clinic. AIDS. 1996; 10(9):1033-9. DOI: 10.1097/00002030-199610090-00015. View